US FDA to hold meeting on developing anticoagulant products in children
This article was originally published in SRA
Executive Summary
A US Food and Drug Administration advisory committee is to hold a public meeting on 2 November to discuss regulatory, academic and industry perspectives regarding the development of anticoagulant products in children1.